missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Lemzoparlimab Recombinant Monoclonal Antibody

Recombinant Monoclonal Antibody
477.00€ - 1204.00€
Spécification
| Antigène | Lemzoparlimab |
|---|---|
| Concentration | 1 mg/mL |
| Contenu et stockage | -20°C, Avoid Freeze/Thaw Cycles |
| Applications | ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance |
| Classification | Recombinant Monoclonal |
| Code produit | Marque | Quantité | Prix | Quantité et disponibilité | |||||
|---|---|---|---|---|---|---|---|---|---|
| Code produit | Marque | Quantité | Prix | Quantité et disponibilité | |||||
30284234
![]() |
Invitrogen™
MA559459 |
100 μg |
477.00€
100µg |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | |||||
|
30283969
|
Invitrogen™
MA559460 |
1 mg |
1204.00€
1mg |
Veuillez vous connecter pour pouvoir commander cet article. Besoin d'un compte web? Créer le vôtre dès maintenant! | |||||
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Lemzoparlimab is an anti-CD47 monoclonal antibody that blocks the CD47-SIRPalpha interaction, promoting phagocytosis of cancer cells by macrophages.Spécification
| Lemzoparlimab | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Recombinant Monoclonal | |
| Lyophilized | |
| IgG4 | |
| Human | |
| ABBV-IMAB-TJC4; TJ-011133; TJ-1133; TJC-4 | |
| Antibody |
| 1 mg/mL | |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| Unconjugated | |
| Human | |
| RUO | |
| 25mM histidine with 8% sucrose, 0.01% Tween 80 and no preservative; pH 6.2 | |
| Primary | |
| Protein A |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title